“ We are very proud of our upcoming IPO: this listing validates the relevance of our technology project, which has now moved into the commercial and industrial deployment phase. Throughout the world, our bio-security innovations are receiving an increasingly enthusiastic reception, particularly at trade shows, with a constantly growing pipeline of order intentions.
Our presence on the stock market represents a strategic development step for Octopus Robots, because it should enable us to increase our visibility and notoriety, especially internationally, and to secure funding to support the expected strong growth of our business”, stated Olivier Somville, founding chairman of Octopus Robots.
Having received a Euronext notice published on 28 February 2018, Octopus Robots, an AgTech(1) pioneer in biosecurity, is pleased to announce its listing by technical admission on the ACCESS compartment of Euronext Paris on Wednesday, 14 March 2018.
This stock market listing will enable Octopus Robots to increase its notoriety quickly and diversify its funding sources in a second phase by appealing to the market as part of its rapid development.
Terms of the operation
|Listing procedure:||Technical admission|
|Number of shares in registered capital:||1,765,944|
|Number of shares sold:||15,000|
|Sale price per share:||€15.07|
|Amount of sale:||€226.01 K;|
|Valuation adopted for listing:||€26,608 K;|
|First listing:||14 March 2018|
|Start of trading:||15 March 2018|
|Eligibility for PEA (equity savings plan) and SME PEA:||yes|
|Listing sponsor:||Atout Capital|
The operation does not require approval from the AMF (French FINANCIAL markets authority). Therefore, the Information Document has not been approved by the AMF. The Information Document is available free of charge at the headquarters of OCTOPUS ROBOTS. It can be downloaded at http://octopusrobots.com/investisseurs/
Companies admitted to Euronext Access are not subject to the same rules as companies on the regulated market. Rather, they are subject to a less extensive body of rules adapted to small growth businesses. The risk associated with an investment on Euronext Access may therefore be greater than investing in a company of the regulated market.
Octopus Robots, a technological breakthrough for biosecurity
In a sensitive health context (new infectious diseases, recurrent health crises, bioûterrorist threats, world pandemic forecasts, antibiotic resistance development, etc.), Octopus Robots offers unique solutions to prevent, tackle and treat bio-contamination.
To this end, the startup has developed a range of robots that help to improve health security at food industry and industrial sites and establishments that are open to the public. Its range is based on innovative patented technology that is unique in the world, the atomisation of liquid substances in the form of dry fog (biocides, vaccines, crop protection products, etc.).
In total, since the launch of the Octopus Robots project in 2014, the company has raised around €3.2M to finance the R&D phase prior to the marketing phase that began at the end of 2017.
The technology developed by Octopus Robots meets market expectations in:
- the food industry (animal husbandry, production, transformation, storage, distribution, etc.)
- human health (establishments open to the public including airports, shopping malls, etc.)
- pharmaceutical laboratories (vaccine production, research units, etc.)
- defence and civil protection (zones with access regulations)
The poultry industry, a priority development area
In the short term, it is the animal husbandry market including poultry farming that represents the greatest potential for sales for the company with an estimated market of 1 million buildings(2) to be treated around the world.
Octopus Robots technology allows a poultry farm to:
- improve the quality of poultry by improving animal well-being and limiting the use of antibiotics
- treat/sanitise the bedding that houses multi-resistant bacteria, spreads infectious diseases and concentrates high levels of ammonia
- uniformly decontaminate buildings during fallow periods
- increase yields through increasing animal weight and reducing interim costs
An offering adapted to different contexts of bio-security
The Octopus Robots range is currently based on a mobile, connected, completely autonomous robot with modular Artificial Intelligence (AI) operational 24 hours a day thanks to its automated recharge base.
The plan foresees the integration of all data collated by the robots to a private blockchain dedicated to product traceability in the long term.
Four versions of the robot are currently available:
- Octopus Scarifier to effectively treat litter in poultry farms, thereby preventing contamination when buildings are left empty for health reasons and lowering ammonia levels,
- Octopus Poultry Safe for antibiotic-free sanitation of large poultry breeding buildings,
- Octopus Poultry Cleaner to detect and evacuate carcasses in poultry farms,
- Octopus Biosafety to decontaminate large volumes (airports, shopping centres, etc.) and prevent the spread of infectious diseases.
Start of production and business outlook
Octopus Robots is currently developing its industrial capabilities and accelerating recruitment in a domestic and international sales force.
The robots are being produced in Cholet (49), France, notably using 3D printing technology to provide full control over and optimisation of the industrial manufacturing process.
Octopus Centres around the world are in the pipeline for robot assembly and providing maintenance, an after-sales service and customer relations.
Octopus Robots started production on its first 10 robots in 4th quarter 2017.
|Advantages of Octopus Robots
An AgTech company focusing on health security, a rapidly growing global market
(1) AgTech: company specialised in state-of-the-art technology to help agriculture and the food industry.
(2) Source: Zion research analysis 2016
Press coverage: http://octopusrobots.com/presse-octopus
About Octopus Robots – www.octopusrobots.com
A French AgTech company, Octopus Robots specialises in the design, manufacture, and marketing of versatile, autonomous mobile robots featuring proprietary artificial intelligence.
These robots are equipped with a patented device to decontaminate large-volume spaces (livestock buildings, agro-industries, establishments open to the public, airports, etc.).
This solution effectively combats multi-resistant bacteria, pandemics and bioterrorism. Multiple on-board sensors ensure full data traceability.
Press kit: www.octopusrobots.com/presse/
Euronext Paris ACCESS compartment
ISIN code: FR0013310281, Mnemo: MLOCT
Eligible for equity savings plan for SMEs
Olivier Somville - CEO
|ATOUT CAPITAL - Listing Sponsor
|CAP VALUE - Press Relations
Gilles Broquelet 01 80 81 5 0 01